Antidepressant Fluoxetine Does Not Appear to Interfere With Key Translational Parameters in the Rat Adjuvant-induced Arthritis Model

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Antidepressant Fluoxetine Does Not Appear to Interfere With Key Translational Parameters in the Rat Adjuvant-induced Arthritis Model. / Seveljevic-Jaran, Dasa; Kalliokoski, Otto; Abelson, Klas S.P.; Hau, Jann.

In: In Vivo, Vol. 36, No. 2, 2022, p. 635-642.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Seveljevic-Jaran, D, Kalliokoski, O, Abelson, KSP & Hau, J 2022, 'Antidepressant Fluoxetine Does Not Appear to Interfere With Key Translational Parameters in the Rat Adjuvant-induced Arthritis Model', In Vivo, vol. 36, no. 2, pp. 635-642. https://doi.org/10.21873/invivo.12747

APA

Seveljevic-Jaran, D., Kalliokoski, O., Abelson, K. S. P., & Hau, J. (2022). Antidepressant Fluoxetine Does Not Appear to Interfere With Key Translational Parameters in the Rat Adjuvant-induced Arthritis Model. In Vivo, 36(2), 635-642. https://doi.org/10.21873/invivo.12747

Vancouver

Seveljevic-Jaran D, Kalliokoski O, Abelson KSP, Hau J. Antidepressant Fluoxetine Does Not Appear to Interfere With Key Translational Parameters in the Rat Adjuvant-induced Arthritis Model. In Vivo. 2022;36(2):635-642. https://doi.org/10.21873/invivo.12747

Author

Seveljevic-Jaran, Dasa ; Kalliokoski, Otto ; Abelson, Klas S.P. ; Hau, Jann. / Antidepressant Fluoxetine Does Not Appear to Interfere With Key Translational Parameters in the Rat Adjuvant-induced Arthritis Model. In: In Vivo. 2022 ; Vol. 36, No. 2. pp. 635-642.

Bibtex

@article{4dfb66a54d6e46a2b6f767fb38f467f9,
title = "Antidepressant Fluoxetine Does Not Appear to Interfere With Key Translational Parameters in the Rat Adjuvant-induced Arthritis Model",
abstract = "BACKGROUND/AIM: This study aimed to investigate the analgesic effects of fluoxetine on Lewis rats of both sexes in the adjuvant-induced arthritis (AIA) rat model. In humans, chronic pain syndromes typical of rheumatoid arthritis (RA) co-exist with depression which is often treated with fluoxetine antidepressant known to have antinociceptive effects. MATERIALS AND METHODS: The experiment was terminated on day 26, after seven days of oral treatment (days 19-25) with fluoxetine and indomethacin. The effects of treatments were assessed on the final day of the study through measuring body weight, serum concentrations of a1-acid glycoprotein, visual arthritis assessment and post mortem histopathology assessment. RESULTS: Statistically significant difference was determined in the body weight of male subjects, with indomethacin-treated animals putting on significantly more weight than the vehicle and fluoxetine-treated counterparts. No differences were found between the different treatment groups in other study assessments. CONCLUSION: The present study did not provide support for analgesic effects of fluoxetine aimed at reducing the severity of the AIA model.",
keywords = "analgesia, fluoxetine, rat model, Rheumatoid arthritis",
author = "Dasa Seveljevic-Jaran and Otto Kalliokoski and Abelson, {Klas S.P.} and Jann Hau",
note = "Publisher Copyright: Copyright {\textcopyright} 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.",
year = "2022",
doi = "10.21873/invivo.12747",
language = "English",
volume = "36",
pages = "635--642",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "2",

}

RIS

TY - JOUR

T1 - Antidepressant Fluoxetine Does Not Appear to Interfere With Key Translational Parameters in the Rat Adjuvant-induced Arthritis Model

AU - Seveljevic-Jaran, Dasa

AU - Kalliokoski, Otto

AU - Abelson, Klas S.P.

AU - Hau, Jann

N1 - Publisher Copyright: Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

PY - 2022

Y1 - 2022

N2 - BACKGROUND/AIM: This study aimed to investigate the analgesic effects of fluoxetine on Lewis rats of both sexes in the adjuvant-induced arthritis (AIA) rat model. In humans, chronic pain syndromes typical of rheumatoid arthritis (RA) co-exist with depression which is often treated with fluoxetine antidepressant known to have antinociceptive effects. MATERIALS AND METHODS: The experiment was terminated on day 26, after seven days of oral treatment (days 19-25) with fluoxetine and indomethacin. The effects of treatments were assessed on the final day of the study through measuring body weight, serum concentrations of a1-acid glycoprotein, visual arthritis assessment and post mortem histopathology assessment. RESULTS: Statistically significant difference was determined in the body weight of male subjects, with indomethacin-treated animals putting on significantly more weight than the vehicle and fluoxetine-treated counterparts. No differences were found between the different treatment groups in other study assessments. CONCLUSION: The present study did not provide support for analgesic effects of fluoxetine aimed at reducing the severity of the AIA model.

AB - BACKGROUND/AIM: This study aimed to investigate the analgesic effects of fluoxetine on Lewis rats of both sexes in the adjuvant-induced arthritis (AIA) rat model. In humans, chronic pain syndromes typical of rheumatoid arthritis (RA) co-exist with depression which is often treated with fluoxetine antidepressant known to have antinociceptive effects. MATERIALS AND METHODS: The experiment was terminated on day 26, after seven days of oral treatment (days 19-25) with fluoxetine and indomethacin. The effects of treatments were assessed on the final day of the study through measuring body weight, serum concentrations of a1-acid glycoprotein, visual arthritis assessment and post mortem histopathology assessment. RESULTS: Statistically significant difference was determined in the body weight of male subjects, with indomethacin-treated animals putting on significantly more weight than the vehicle and fluoxetine-treated counterparts. No differences were found between the different treatment groups in other study assessments. CONCLUSION: The present study did not provide support for analgesic effects of fluoxetine aimed at reducing the severity of the AIA model.

KW - analgesia

KW - fluoxetine

KW - rat model

KW - Rheumatoid arthritis

U2 - 10.21873/invivo.12747

DO - 10.21873/invivo.12747

M3 - Journal article

C2 - 35241516

AN - SCOPUS:85125690601

VL - 36

SP - 635

EP - 642

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 2

ER -

ID: 300066186